Elicio Therapeutics Inc (ELTX)
8.98
-0.02
(-0.22%)
USD |
NASDAQ |
May 03, 16:00
8.83
-0.15
(-1.67%)
After-Hours: 20:00
Elicio Therapeutics Shareholders Equity (Quarterly): 11.37M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.37M |
| September 30, 2023 | 13.29M |
| June 30, 2023 | 23.56M |
| Date | Value |
|---|---|
| December 31, 2022 | -102.14M |
| March 31, 2021 | -54.87M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-102.14M
Minimum
Dec 2022
23.56M
Maximum
Jun 2023
-21.76M
Average
11.37M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Immuneering Corp | 90.58M |
| Oragenics Inc | 3.168M |
| Outlook Therapeutics Inc | -24.34M |
| Amylyx Pharmaceuticals Inc | 433.43M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.15M |
| Total Liabilities (Quarterly) | 15.77M |